Sachs conference
25 February 2008
Lipoxen plc
Lipoxen plc presenting at: Sachs Associates, 7th Annual North America Forum for Investing & Partnering in Biotech London, UK, 25th February, 2008
Lipoxen PLC (AIM: LPX) a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs, today announces that M. Scott Maguire, Chief Executive Officer, will be presenting at the Sachs Associates, 7th Annual North America Forum for Investing & Partnering in Biotech at the Fairmont Copley Plaza on 25th February, 2008 at 11am EST.
The presentation and further company information will be available at www.lipoxen.com
Enquiries:
Lipoxen plc
|
|
+44 (0)20 7691 3583
|
M. Scott Maguire, Chief Executive Officer
|
|
|
Colin Hill, Finance Director
|
|
|
|
|
|
Landsbanki Securities (UK) Limited
|
|
+44 (0)20 7426 9000
|
Shaun Dobson
|
|
|
Claes Spång
|
|
|
|
|
|
Citigate Dewe Rogerson
|
|
+44 (0)20 7638 9571
|
David Dible
|
|
|
Emma Palmer
|
|
|
Download the presentation